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Research
Arsenic represents a global environmental 
health threat and a known human carcino-
gen. More than 100,000 individuals in New 
England are exposed to arsenic levels in drink-
ing water that exceed federal standards [U.S. 
Environmental Protection Agency (EPA)], 
and 500 million people worldwide are at risk 
of exposure from contaminated groundwa-
ter (Mead 2005). Studies linking arsenic to 
adverse human health effects such as lung, 
bladder, and skin cancer were instrumental 
in motivating recent U.S. policy changes low-
ering maximum allowable limits in drink-
ing water from 50 ppb to 10 ppb (U.S. EPA 
2006). However, the effects of exposure to 
low levels of arsenic also remain unclear.
Exposure to very low levels of arsenic 
(< 10 ppb) is linked to adverse biological effects, 
including endocrine disruption and alteration 
in cell cycle kinetics, cell signaling, and the 
proliferative response (Rossman et al. 2004). 
Arsenic levels commonly found in contami-
nated drinking water in the U.S. elicit changes 
in gene expression profiles in a number of criti-
cal gene networks (Andrew et al. 2007), alter 
the vertebrate innate immune response (Nayak 
et al. 2007), and interfere with DNA repair pro-
cesses (Andrew et al. 2006). Genomic profiling 
studies have reported that moderate changes in 
low-level exposure conditions elicited different 
expression profiles, suggesting arsenic affects 
biological systems at low levels, and these effects 
are very complex (Andrew et al. 2003).
In a human study in Argentina, Concha 
et al. (1998) found fetal arsenic levels similar to 
levels detected in mothers exposed via drink-
ing water, indicating that arsenic crosses the 
placenta. Arsenic can affect placental vasculo-
genesis and increase the rate of spontane-
ous abortions (Andrew et al. 2006; He et al. 
2007); cause epigenetic modifications (Xie 
et al. 2007); and induce neural tube defects, 
cause axial skeletal abnormalities, and reduce 
mean fetal weight in transplacentally exposed 
mice without evidence of maternal toxicity 
(Hill et al. 2008). Gene expression studies 
in exposed mouse fetal liver cells recapitulate 
those associated with transplacental arsenic-
induced mouse liver tumors (Liu et al. 2008).
Early environmental challenges can affect 
disease susceptibility later in life in the absence 
of apparent alterations in normal developmen-
tal programs (Hales and Barker 2001; Newbold 
2004; Newbold et al. 2006; Ravelli et al. 1998; 
Vickers et al. 2007). Diseases postulated to have 
developmental windows of vulnerability include 
cancers and neurologic, reproductive, and met-
abolic dis  orders (Birnbaum and Fenton 2003; 
Davey et al. 2007; Ho et al. 2006; Lahiri et al. 
2007; Weidman et al. 2007). In utero exposure 
in mice was associated with dose-related adult-
onset liver cancer, adrenal cortical adenoma in 
male offspring, and ovarian tumors and lung 
cancer in female offspring (Shen et al. 2007; 
Waalkes et al. 2007). The molecular basis of 
these correlations is largely unknown.
Emerging evidence from evolutionarily 
divergent species suggests that the immune 
response is compromised by low levels of 
arsenic and likely reflects functional dis-
ruption of critical genes and networks. An 
over  representation of genes involved in 
immuno  suppression was correlated with arse-
nic exposure (Andrew et al. 2008), and arsenic 
down-regulated genes involved in immune 
modulation in mouse embryonic cells (Yu 
et al. 2008). Low levels of arsenic also reduced 
immune and defense responses in birds and 
fish (Aggarwal et al. 2008; Andrew et al. 2008; 
Yu et al. 2008). Additional studies in a trac-
table model are needed to better understand 
the extent to which arsenic perturbs regulatory 
networks involved in immune response during 
development.
The zebrafish (Danio rerio) is an ideal 
model for studying developmental toxicol-
ogy and for understanding the connections 
between environmental exposures and human 
diseases (Pichler et al. 2003). Zebrafish are 
highly fecund with short generation times of 
3–5 months. Eggs are fertilized externally and 
are relatively large (0.6 mm), transparent, and 
readily manipulated (Mattingly et al. 2001; 
Pichler et al. 2003). Rapid development from 
a zygote to the hatching period (~ 48 hr) pro-
vides advantages over mammalian models for 
observing organo  genesis. Zebrafish are signifi-
cantly more economical to maintain than are 
mammalian models, enabling more experi-
mental opportunities (Pichler et al. 2003). 
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Ba c k g r o u n d: Exposure to arsenic is a critical risk factor in the complex interplay among genetics, 
the environment, and human disease. Despite the potential for in utero exposure, the mechanism of 
arsenic action on vertebrate development and disease is unknown.
oBjectives: The objective of this study was to identify genes and gene networks perturbed by arsenic 
during development in order to enhance understanding of the molecular mechanisms of arsenic action.
Me t h o d s : We exposed zebrafish embryos at 0.25–1.25 hr postfertilization to 10 or 100 ppb 
arsenic for 24 or 48 hr. We then used total RNA to interrogate genome microarrays and to test 
levels of gene expression changes by quantitative real-time polymerase chain reaction (QPCR). 
Computational analysis was used to identify gene expression networks perturbed by arsenic during 
vertebrate development.
re s u l t s: We identified a set of 99 genes that responded to low levels of arsenic. Nineteen of these 
genes were predicted to function in a common regulatory network that was significantly associated 
with immune response and cancer (p < 10–41). Arsenic-mediated expression changes were validated 
by QPCR.
co n c l u s i o n s: In this study we demonstrated that arsenic significantly down-regulates expression 
levels of multiple genes potentially critical for regulating the establishment of an immune response. 
The data also provide molecular evidence consistent with phenotypic observations reported in other 
model systems. Additional mechanistic studies will help explain molecular events regulating early 
stages of the immune system and long-term consequences of arsenic-mediated perturbation of this 
system during development.
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Zebrafish resources are abundant, including 
a sequenced genome, micro  array resources, 
and cDNA libraries. Despite the evolution-
ary distance separating zebrafish and humans 
(~ 400 million years), it is an important 
model of human diseases such as cranio  facial, 
hemato  poietic, cardio  vascular, and neuro-
degenerative disorders and cancer (Goessling 
et al. 2007; Lieschke and Currie 2007). Large-
scale genetic screens have produced zebrafish 
mutants with phenotypes similar to human 
disorders (Goessling et al. 2007; Lieschke 
and Currie 2007). The combination of these 
features make the zebrafish uniquely suited 
for investigating the effects of environmental 
exposures and the consequences on vertebrate 
development.
In this study we aimed to identify genes 
and networks targeted by low levels of arsenic 
during vertebrate embryonic development. We 
exposed zebrafish embryos to arsenic; evalu-
ated effects on transcription by whole genome 
micro  array analysis, gene enrichment, and path-
way analyses; and confirmed results by quantita-
tive reverse transcriptase (RT) polymerase chain 
reaction (QPCR). Here we describe the effects 
of arsenic on the expression levels of a cohort 
of genes predicted to affect multiple vertebrate 
immune response processes. 
Materials and Methods
Zebrafish. Wild-type AB zebrafish were main-
tained on a 14/10-hr light/dark cycle at the 
zebrafish facility of the University of Maine–
Orono in a recirculating system with water at 
28.5°C and a flow rate of 150 L/min. Animal 
husbandry was in accordance with the uni-
versity’s Institutional Animal Care and Use 
Committee standards. Animals were treated 
humanely and with regard for alleviation of 
suffering.
Arsenic exposures. Zebrafish adults were 
spawned; embryos were then collected, scored 
for viability, and sorted by develop  mental 
stage. We used embryos between 2-cell and 
16-cell stage [0.25–1.5 hr postfertilization 
(hpf)] exclusively for the studies described here.
For microarray analysis, we exposed pooled 
samples of 50 zebrafish to 0, 10, or 100 ppb 
sodium meta-arsenite (NaAsO2; As3+; Fluka, 
St. Louis, MO) up to 48 hpf. These concentra-
tions are environmentally rele  vant and do not 
cause toxicity. All exposures were in 0.5 × E2 
media (7.5 mM NaCl, 0.25 mM KCl, 0.5 mM 
MgSO4, 0.075 mM KH2PO4, 0.0025 mM 
Na2HPO4, 0.5 mM CaCl2, and 0.35 mM 
NaHCO3). Embryos were kept at a density of 
3–4/mL with one medium change per 24 hr. 
All exposures and controls were performed in 
triplicate in plastic Petri dishes at 28.5°C.
For QPCR analysis, we exposed pooled 
samples as described above, except that 
embryos were exposed at 24 hr. Four or five 
biological replicates were performed in plastic 
Petri dishes at 28.5°C.
RNA extraction and reverse transcrip-
tion. Total RNA was recovered from whole 
embryos using TRIzol (Invitrogen, Carlsbad, 
CA) according to the manufacturer’s proto-
col. We assessed RNA used for micro  array 
and QPCR experiments by microchip analy-
sis on an Agilent 2100 Bioanalyzer (Agilent 
Technologies, Foster City, CA). First-strand 
cDNA was synthesized from 2 mg of total 
RNA using Moloney murine leukemia virus 
RT from a RETROscript kit (Ambion, 
Austin, TX) according to the manufacturer’s 
protocol. Total RNA without RT were used 
as negative controls. 
Microarray analysis.  We performed 
microarray analysis to evaluate the effects of 
arsenic exposure on global transcription during 
zebrafish development. Total RNA (~ 10 µg 
per biological replicate) was sent to the 
Affymetrix Core Facility of the Oregon Health 
and Sciences University (Portland OR), where 
micro  array analyses were performed in triplicate 
on Affymetrix GeneChip Zebrafish Genome 
arrays consisting of 14,900 transcripts, for a 
total of nine independent arrays: three con-
trols, three low-  concentration As3+ (10 ppb) 
exposures, and three high-  concentration As3+ 
(100 ppb) exposures.
Sample labeling. We converted RNA to 
double-stranded cDNA using Superscript 
Reverse Transcriptase (Invitrogen) and an 
oligo-dT primer linked to a T7 RNA poly-
merase binding site sequence. Amplified and 
labeled cRNA (“target”) was produced by 
in vitro transcription using T7 RNA poly-
merase, biotin-UTP, and biotin-CTP (Enzo 
Diagnostics, Inc., Farmingdale, NY). Target 
yield was meas  ured by ultraviolet absorbance 
(λ260).
Array hybridization and processing. We 
fragmented labeled target at 95°C in the pres-
ence of high [Mg2+] and combined with bio-
tinylated hybridization control oligomer and 
biotinylated control cRNAs for BioB, BioC, 
BioD, and CreX (Affymetrix) in hybridization 
buffer. We hybridized 10 µg of target with the 
arrays overnight, followed by washing, staining 
with streptavidin-phyco  erythrin (Molecular 
Probes, Carlsbad, CA), signal amplification 
Table 1. Genes and primers analyzed by QPCR.
  Fold changea  Gene    Amplicon
Gene symbol (name)b  10  100  accession ID   Primer sequence  (bp)
akt2 (v-akt murine thymoma viral oncogene homolog 2)  –2.4  NC  NM_198146  5´-GAGATCAGCGTCGTCAGAGA-3´ (F)
        5´-AGCCGATAAAAGAGCCATCA-3´ (R)  106
ass1 (argininosuccinate synthetase 1)  –2.0  NC  NM_001004603  5´-GGAGGATCGATATCGTGGAG-3´ (F)
        5´-GTCCAGATGAGCCTGAAGGA-3´ (R)  127
C3 (similar to complement C3)  NC  –2.0  XM_001343352  5´-GCTGTGCACGTCCTTAACAA-3´ (F)
        5´-CATCTCTTCCACCTCCTGCT-3´ (R)  103
fn1 (fibronectin 1)  –1.8  –1.7  NM_131520  5´-TGCGGCACGACTTATAACTTT-3´ (F)
        5´-TCACACCCTCATTGGTGGTA-3´ (R)  94
foxo5 (forkhead box O5)  –1.9  NC  NM_131085  5´-TGAATGGGAGGAGAGGTGTT-3´ (F)
        5´-GTCACATTCGCATTCCATGA-3´ (R)  100
gapdh (glyceraldehyde-3-phosphate dehydrogenase)  Norm  Norm  NM_001115114  5´-TGGGCCCATGAAAGGAAT-3´ (F)
        5´-ACCAGCGTCAAAGATGGATG-3´ (R)  94
nfkb2 (nuclear factor of kappa light polypeptide gene  –2.3  NC  NM_001001840  5´-TGAATGGGAGGCATTAGGAG-3´ (F)
  enhancer in B-cells 2)        5´-ACAGGTCGATCGATGTTGGT-3´ (R)  105
notch1a (notch homolog 1a)  –2.3  –2.0  NM_131441  5´-TGACGTTAACGAGTGCCTGT-3´ (F)
        5´-GCTTCCCGGTGTATCCTGTA-3´ (R)  110
notch1b (notch homolog 1b)  –2.0  –2.0  NM_131302  5´-ATTGATGATGTGGCCGGATA-3´ (F)
        5´-TCATTTCGGCAAGGATTTTT-3´ (R)  114
pik3r1 (similar to phosphoinositide-3-kinase, regulatory  –1.9  –1.7  XM_678727  5´-GATGATACGCATCGCTCAAG-3´ (F)
  subunit, polypeptide 1)        5´-TGTGGAGGAAGTGCAGTTGA-3´ (R)  90
plg (plasminogen)  NC  NC  NM_201472  5´-ATGGAGCCTCATCGACATTC-3´ (F)
        5´-TAACACCAAGGGGCTCTGTC-3´ (R)  104
Abbreviations: F, forward primer; NC, no change; Norm, normalizer; R, reverse primer. 
aFold change in gene expression between As3+ (10 or 100 ppb) and control (0 ppb) experiments as determined by QPCR analysis. FC = –1/(2∆∆Ct), where ∆∆Ct = ∆Ct,exposed – ∆Ct,control. ∆Ct,exposed 
and ∆Ct,control are the normalized threshold cycles for exposed and control samples, respectively. bOfficial zebrafish gene symbols and gene accession numbers from NCBI (2009). Perturbation of immune response pathways by As3+
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with biotinylated anti-streptavidin antibody 
(Vector Laboratories, Burlingame, CA), and a 
final staining step on the Fluidics Station 400 
(Affymetrix). The distribution of fluorescent 
material on the processed array was determined 
using the Affymetrix GeneChip laser scanner; 
image inspection was performed manually. 
We created Affymetrix data files [cell inten-
sity (CEL) files] from each array using GCOS 
(GeneChip Operating Software; Affymetrix). 
Statistical analysis. We implemented a 
statisti  cal process similar to the one reported by 
Gosse et al. (2008). Probe-level data from CEL 
files were normalized using robust multi  array 
analysis (Irizarry et al. 2003) as implemented 
in Bioconductor (http://www.bioconductor.
org). Quality control was performed using log-
ratio versus log-product (MA) plots and vol-
cano plots (data not shown). Probes with a 
substantial likelihood of differential expression 
under treatment conditions were identified 
using simple t-tests combined with mean fold 
change in accordance with recommendations 
from the Microarray Quality Control (MAQC) 
Consortium (Guo et al. 2006; Shi et al. 2006). 
We selected a t-test p-value threshold of 0.1 
and a minimum absolute fold difference of 1.4 
between the controls and exposed data sets. 
This approach yielded 99 genes that were hier-
archically clustered (Eisen et al. 1998), which 
we used in pathway analysis.
Molecular pathway, gene ontology, and 
Comparative Toxicogenomics Database (CTD) 
analysis. To identify affected molecu  lar path-
ways and biological processes, we compu-
tationally analyzed arsenic-responsive genes 
identified by microarray analysis. We identified 
human orthologs of affected zebra  fish genes 
by deriving orthologs from Affymetrix anno-
tations, by BLAST (Basic Local Alignment 
Search Tool) database [National Center for 
Biotechnology Information (NCBI) 2009] 
analysis of Affymetrix probe sequences (recip-
rocal and BLASTX) or by computational 
genome mapping. Orthologous human 
gene symbols were analyzed using Ingenuity 
Pathway Analysis (IPA) software (Ingenuity 
Systems, Redwood City, CA). Gene ontology 
assignments (Ashburner et al. 2000) and clus-
tering into functional groups were performed 
using DAVID (Database for Annotation, 
Visualization, and Integrated Discovery)
(Dennis et al. 2003). Microarray-derived gene 
expression changes were compared with manu-
ally curated arsenic–gene/protein interactions 
archived in CTD (CTD 2009; Davis et al. 
2008, 2009). We used the CTD Batch Query 
tool (http://ctd.mdibl.org/tools/batchQuery.
go) to retrieve all curated chemical–gene inter-
actions for the terms “arsenic” and “arsenicals.”
QPCR analysis. We performed QPCR anal-
ysis on an Mx3000P Real-Time PCR system 
(Stratagene, La Jolla, CA) using the Brilliant 
SYBR Green QPCR reagent kit (Stratagene) 
according to the manufacturer’s protocol. The 
cycling parameters were 95°C for 10 min, fol-
lowed by 40 cycles of 95°C for 30 sec, 55°C for 
60 sec, and 72°C for 60 sec. Threshold cycles 
(Ct) and dissociation curves were determined 
with MxPro software (Stratagene), and gene 
expression levels were normalized to zebrafish 
Gapdh.Standard curves and primer efficien-
cies were determined for all genes analyzed by 
QPCR. Primer sequences are listed in Table 1.
Results
Arsenic-mediated perturbation of gene tran-
scription. We implemented several strategies 
during the statistical analysis of the micro  array 
data sets. First, an uncorrected t-test identified 
766 genes differentially expressed between con-
trol and treated samples (p < 0.05). However, 
data sets composed of > 15,600 measurements 
are expected to yield > 770 measurements by 
chance with p < 0.05. After correcting for mul-
tiple hypothesis testing (Bonferroni correction), 
none of the genes rose to the level of signifi-
cance. Other parametric tests performed simi-
larly. Second, we implemented a non  parametric 
fold-change ranking approach as recommended 
by the MAQC Consortium (Guo et al. 2006; 
Shi et al. 2006) by which we selected genes 
with a) at least a ± 1.4-fold change between 
control and exposed data sets and b) substan-
tial within-group consistency as evidenced by 
a two-tailed t-test p-value ≤ 0.1. This approach 
yielded 99 differentially expressed genes, of 
which 55 had an uncorrected p-value ≤ 0.05. 
This refined data set was hierarchically clustered 
to produce the heat map shown in Figure 1, 
Figure 1. Hierarchical clustering of transcripts significantly modified by exposure to arsenic for 48 hr. 
Transcripts were selected by a fold-change ranking approach implemented in R (R Development Core 
Team 2009) using an absolute fold change of 1.4 and a threshold (p-value) of 0.1. Each column represents 
the expression level of a probe set in a pooled group of 50 animals (green and red indicate decreased and 
increased expression, respectively). Arrays are grouped by arsenic concentration [control (0 ppb), 10 ppb, 
and 100 ppb]. Transcripts were clustered by hierarchical clustering using the complete linkage algorithm 
and Pearson correlation metric in R. Mattingly et al.
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revealing a pattern suggesting concentration-
dependent effects even though corrected 
p-values for this ranked set did not rise to the 
significance level of ≤ 0.05. Control (Figure 1, 
columns 1 and 2) and high-As3+–exposed 
(Figure 1, columns 6–8) biological replicates 
exhibited consistent reproducibility among 
replicates, whereas low-As3+–exposed replicates 
(Figure 1, columns 3–5) did not. For example, 
biological replicates 1 and 2 of the 10-ppb As3+ 
set (columns 3 and 4) were consistent with each 
other, whereas replicate 3 (column 5) exhibited 
a response in line with the biological replicates 
treated with 100-ppb As3+.
Computational prediction of an arsenic-
modulated molecular network affecting 
immune response. We used IPA to identify 
molecular relationships among genes predicted 
by micro  array analysis to be differentially 
expressed in response to arsenic. In addition, 
non  input molecules are inserted by IPA in 
order to merge small networks generated from 
user data. We identified orthologous human 
genes for 79 of the 99 differentially expressed 
zebrafish genes described above. Among these, 
64 were in the IPA knowledge  base. IPA identi-
fied a highly significant network (p < 10–41) 
containing 20 of the 64 (31%) input genes and 
15 bridging genes (Figure 2). This network was 
significantly associated with immune response, 
cancer, and gastro  intestinal disease (p ≤ 0.02). 
Genes within this network are involved in 
specific immune functions such as comple-
ment activation (p ≤ 2.8 × 10–6), migration 
of immune response cells (e.g., monocytes, 
macro  phages; p < 9.2 × 10–3), and respiratory 
burst (p < 1.2 × 10–2). The IPA-derived net-
work also contained three genes (cugbp2, foxo5, 
and pik3r1) predictive of prenatal arsenic expo-
sure based on a recent epidemiologic study 
(Fry et al. 2007), two of which (foxo5 and 
pik3r1) were observed in the 99 genes identi-
fied by the micro  array analysis. These results 
support the hypothesis that the zebrafish is a 
valuable model organism for understanding the 
complex mechanisms of arsenic action during 
vertebrate development.
IPA results were corroborated by a gene 
ontology enrichment analysis conducted 
using the online Functional Annotation 
Clustering tool from DAVID (Dennis et al. 
2003). Among the 79 differentially expressed 
genes with identifiable human orthologs, the 
“immune response” biological process [Gene 
Ontology (GO) ID no. GO:0006955 (The 
Gene Ontology 2009)] was significantly over-
represented (p < 0.05). Analysis using the same 
79 genes from the micro  array analysis plus the 
15 bridging genes from IPA yielded a subset 
of GO terms, 53% of which were associated 
with the immune system or defense responses 
(Table 2).
CTD analysis. CTD contains a robust 
data set for arsenic that describes molecu-
lar inter  actions between 20 different arsenic 
compounds and 1,709 genes and proteins 
(Davis et al. 2008). Comparison of the 79 dif-
ferentially expressed genes from the micro-
array analy  sis with curated arsenic-  interacting 
genes in CTD yielded an over  lapping set 
of 11 genes. Among these 11 genes, 5 were 
members of the predicted pathway (Figure 2, 
circled genes). CTD also corroborated 5 of the 
15 bridging genes inserted by IPA (Figure 2, 
boxed genes). These genes were present on the 
micro  arrays but were not included in the top 
99 genes identified by non  parametric rank-
based analysis.
Figure 2. Predicted arsenic-modulated network. Differentially expressed genes in control versus arsenic-
treated embryos were analyzed by IPA software to identify common regulatory networks. Nineteen genes 
identified by microarray analysis were shown to function coordinately in a network associated with can-
cer, gastrointestinal diseases, and immune response (p < 10–41), conditions known to be associated with 
arsenic exposure. Curated arsenic–gene and protein interactions in CTD corroborated 10 of the genes in 
this network—5 that derived from our microarray experiment (circled) and 5 that were inserted by IPA as 
bridging genes (boxed).
Table 2. Immune processes enriched with genes perturbed by arsenic.
    Gene     
GO IDa  GO process  count  p-Value  Human genesb
GO:0002253  Activation of immune response  4  3.97 × 10–3  C3, C4B, C9, CFHR1
GO:0006952  Defense response  8  1.81 × 10–2  C3, C4B, C9, CFHR1, FN1, INS, 
       P2RY11, TCIRG1
GO:0009605  Response to external stimulus  8  3.07 × 10–2  A2M, C3, C4B, C9, CFHR1, FN1, 
       INS, PLG
GO:0006950  Response to stress  10  6.45 × 10–2  APOA4, C3, C4B, C9, CFHR1, 
       CSNK1D, EPAS1, FN1, INS, PLG
GO:0006955  Immune response  9  7.12 × 10–2  C3, C9, C4B, CFHR1, CTSW, 
       GBP1, NFKB2, NOTCH1, TCF12
GO:0002520  Immune system development  4  8.25 × 10–2  FOXO3, NFKB2, NOTCH2, PIK3R1
aData from The Gene Ontology (2009). bData from NCBI (2009). Perturbation of immune response pathways by As3+
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CTD also supported arsenic-associated GO 
terms and diseases identified by DAVID and 
IPA. The most common disease categories asso-
ciated with arsenic in CTD include immune 
system diseases, neoplasms, nervous system 
diseases, skin diseases, digestive system diseases, 
and metabolic disorders (Davis et al. 2008). 
Results from IPA network analysis, microarray 
analysis, and data mining of CTD converged, 
reinforcing the potential effects of arsenic on 
this predicted network.
Quantitative analysis of transcript levels 
of IPA network genes. We analyzed a total 
of 10 genes within the network by QPCR: 
6 derived from the micro  array study (C3, fn1, 
foxo5, notch1a, notch1b, and plg; Figure 2); 
2 derived from the micro  array study and cor-
roborated by CTD (ass1, pik3r1), and 2 bridg-
ing genes corroborated by CTD (akt2, nfkb2). 
We selected a 24-hr time point in order to 
analyze the effects of As3+ on genes poten-
tially regulating the immune response dur-
ing develop  mental stages earlier than the one 
analyzed by micro  array. As shown in Figure 3 
and Table 1, the genes selected for this analy-
sis were down-regulated by As3+. Remarkably, 
this gene set exhibited a more robust and 
significant response to the lowest levels of 
As3+ (10 ppb) compared with responses to 
10-fold higher levels of As3+ (9 of 11 genes vs. 
6 of 11). Only 4 of the 11 genes tested showed 
similar responses to As3+ at both concentra-
tions: fn1, notch1a, notch1b, and pik3r1. One 
gene, plg, had no expression change in control 
versus treated embryos, even though it was 
identified through microarray analysis to be 
affected by As3+.
We identified canonical pathways associ-
ated with these nine arsenic-responsive genes 
using IPA (Figure 4). Many of the pathways 
were involved in immune function, the most 
significant being acute-phase response signal-
ing. Other pathways included lympho  toxin 
receptor signaling, interleukin signaling, 
CD28 signaling, Trem1 (triggering receptor 
expressed on myeloid cells 1) signaling, and 
the complement system. Collectively, gene 
ontology and pathway enrichment analyses 
of micro  array and QPCR results demonstrate 
that arsenic perturbs genes and networks that 
are involved in the immune response during 
vertebrate development.
Discussion
In this article we study the effect of As3+ expo-
sure on the transcription profile of zebrafish 
embryos at 24 and 48 hpf by QPCR and 
microarray analysis, respectively. QPCR 
results demonstrate statistically significant 
down-regulation of multiple genes with criti-
cal functions in immune system development 
and, by inference, immunity at 24 hpf. In 
contrast, micro  array analysis performed at 
48 hpf reveals the opposite pattern: Genes 
down-regulated at 24 hpf are up-regulated at 
48 hpf in the presence of As3+. The micro  array 
analysis provided a robust target gene set that 
underwent changes in expression due to As3+ 
exposure, even though the set was below the 
threshold of significance as determined by sta-
tistical analysis. This observation underscores 
the need to take into account that low-dose 
exposures may not result in dramatic changes 
in gene expression that stand up to rigorous 
statistical tests but nevertheless contribute to 
significant biological effects that can be vali-
dated (Gosse et al. 2008).
The genes we evaluated by QPCR showed 
expression changes for at least one exposure 
concentration and in many cases for both. For 
example, fn1, notch1a, notch1b, and pik3r1 
were down-regulated at least 1.7-fold by both 
10 and 100 ppb As3+ compared with controls, 
whereas akt2, ass1, and nfkb2 responded sig-
nificantly to 10 ppb As3+ (fold change ≥ 2) 
but not to 100 ppb As3+. Conversely, C3 was 
down-regulated 2-fold by 100 ppb As3+ but 
showed no effect to 10 ppb As3+ exposures. 
This variable As3+ concentration-dependent 
phenomenon has been observed before. In a 
study by Bodwell et al. (2004), the effects of 
As3+ on activation of a reporter gene driven 
by a glucocorticoid-regulated promoter were 
stronger at low concentrations. In fact, they 
observed 75% of the maximal induction at 
6 ppb As3+, with a peak at 60 ppb As3+, drop-
ping off rapidly at higher concentrations to 
below basal levels of expression.
In the present study, IPA analysis identi-
fied a gene network containing 20 of 79 genes 
Figure 3. QPCR results for genes identified by microarray and CTD analysis to be affected by 24-hr expo-
sure to As3+. Bars represent expression changes (mean fold change ± SD) compared with the correspond-
ing control. With the exception of ass1, genes are involved in immune response. For each gene, initial 
error bars shown alone indicate control values.
*p < 0.05. 
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identified by micro  array analysis (Figure 2). 
We found two genes, foxo5 (the zebrafish 
ortholog of human FOXO3A) and pik3r1, in 
a group of 170 “sentinel” genes reported as 
predictive of transplacental As3+ exposure in 
infants (Fry et al. 2007). Additionally, bridg-
ing genes inserted into the network by IPA 
included akt2, cugbp2, nfkb2, and pi3k. The 
genes akt2, nfkb2, and pi3k are network hubs 
linking most genes within the set of 20 genes, 
and akt2 and pi3k are members of the Akt/
PI3K signal transduction axis important for 
insulin function, whereas nfkb2 is required 
for immune processes (Speirs et al. 2004). 
Fry et al. (2007) identified nfkb2 as one of 
two hub genes composing a sub  network 
enriched with pro  inflammatory genes that 
were arsenic responsive. The concordance 
of arsenic-  mediated effects in humans and 
zebrafish reinforces the immune system as a 
target of arsenic action and underscores the 
power of zebrafish as a vertebrate model for 
elucidating the effects of As3+ exposure during 
  embryogenesis.
Epidemiologic studies have linked expo-
sure to inorganic arsenic (As3+) to multiple 
human diseases (Hughes 2006). Several of 
these diseases, most notably cancer, might 
be rooted in an abnormal immune response. 
Arsenic is linked to disrupted expression of 
specific tumor suppressors by processes that 
alter promoter methylation patterns and lead 
to higher incidences of cancer, including blad-
der and lung, in exposed populations (Marsit 
et al. 2006). This finding, coupled to results 
demonstrating that As3+ interferes with DNA 
repair (Andrew et al. 2006), raises the possibil-
ity that arsenic may lead to trans  generational 
effects in unexposed individuals via epigenetic 
mechanisms. Studies demonstrate that very 
low-level exposures (in the range of 2–10 ppb) 
during zebrafish embryogenesis affect the 
innate immune system’s ability to respond to 
bacterial and viral pathogens at time points 
when the adaptive immune system is not fully 
developed (Nayak et al. 2007). Inorganic arse-
nic decreases levels of T-cell–secreted cyto-
kines in exposed humans (Biswas et al. 2008); 
interferes with lung epithelial wound repair 
in vivo and in vitro (Olsen et al. 2008); dras-
tically down-regulates expression levels of 
genes required for B-cell antigen recognition, 
humoral immune response, and antigen bind-
ing (Andrew et al. 2007a); inhibits monocyte-
to-macrophage maturation in vitro (Sakurai 
et al. 2006); and decreases proliferation of 
CD4+/CD8+ T lymphocytes in vitro (Tenorio 
and Saavedra 2005). In addition, immune-
related inflammation disorders or activation 
of inflammation signaling pathways have 
been observed in humans and rodents chroni-
cally exposed to As3+ (Fry et al. 2007; Straub 
et al. 2007; Vahidnia et al. 2007; Wu et al. 
2003). These results establish a link between 
As3+ exposure and immune disorders, yet with 
the exception of work by Nayak et al. (2007), 
they do not indicate whether the effects are 
restricted to disrupting the function of specific 
populations of differentiated cells or if exposure 
at early stages of development leads to abnor-
mal immune responses. Nayak et al. (2007) 
meas  ured a significant decrease in expression of 
several immune system modulators, including 
members of the interleukin family, in juvenile 
fish previously exposed to low levels of As3+. 
However, insight into arsenic-mediated effects 
on the embryonic transcriptome requires more 
attention in order to gain greater insight into 
the effects of arsenic on the immune system 
and associated dis  orders.
Conclusion
This study shows that the zebrafish is a valu-
able model organism to enhance under-
standing of the effects of arsenic on aspects 
of embryology, including networks affecting 
immune development. The networked genes 
uncovered by this study are highly evolution-
arily conserved at various levels, including 
conservation of chromosomal synteny (data 
not shown). In addition, there is significant 
overlap between the results of this study and 
observations made by others. These data 
enhance understanding about developmen-
tal responses induced by arsenic and provide 
novel insight into the molecular actions of 
arsenic on the immune system.
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